News for Dyadic International, Inc. (DYAI)

Dyadic International, Inc. (”œDyadic”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered

Dyadic International (DYAI) has introduced a significant leadership change as part of its strategic transition towards becoming a revenue-generating entity. The

Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth marketsLeadership team realigned in order to enable exe

Dyadic International (DYAI) appoints Joe Hazelton as President to support its strategic shift towards ancillary protein products. The company has establ

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NDYAI.OQ - Dyadic International IncQ1 2025 Dyadic International Inc Earnings CallMay 14, 2025 /

Dyadic International (DYAI) will announce its Q1 2025 financial results on May 14, 2025, at 5:00 PM ET. Investors can participate in the earnings call u

JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (”œDyadic”, ”œwe”, ”œus”, ”œour”, or the ”œCompany”) ( DYAI), a biot

**media[612147]**

\n Dyadic International (DYAI) to present its C1 Platform at the 2025 World Vaccine Congress in Washington, D.C. CEO Mark Emalfarb to discuss biomanufactur

Dyadic International, Inc. (NASDAQ:DYAI) Q4 2024 Earnings Conference Call March 26, 2025 5:00 PM ETCompany ParticipantsPing Rawson - Chief Financial...

**media[577748]**

Dyadic International Inc (DYAI) is set to release its Q4 2024 earnings on March 26, 2025. The consensus estimate for Q4 2024 revenue is $1.60 million, and the e

JUPITER, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (”œDyadic”, ”œwe”, ”œus”, ”œour”, or the ”œCompany”) ( DYAI), a bi

JUPITER, Fla., March 12, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (”œDyadic”, ”œwe”, ”œus”, ”œour”, or the ”œCompany”) ( DYAI), a bi

JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (”œDyadic”, ”œwe”, ”œus”, ”œour”, or the ”œCompany”) ( DYAI), a bio

**media[506840]**

California-based clinical-stage biopharmaceutical company Revelation Biosciences, Inc. (REVB) is up over 125 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyad

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ETCompany ParticipantsPing Rawson - CFOMark Emalfarb -...